Market Cap | 2.88B | P/E | 6.34 | EPS this Y | 381.20% | Ern Qtrly Grth | - |
Income | 76M | Forward P/E | 7.34 | EPS next Y | 16.90% | 50D Avg Chg | 10.00% |
Sales | 7.49B | PEG | 1.53 | EPS past 5Y | -15.09% | 200D Avg Chg | 13.00% |
Dividend | N/A | Price/Book | 0.39 | EPS next 5Y | 5.00% | 52W High Chg | -6.00% |
Recommedations | 3.00 | Quick Ratio | 1.55 | Shares Outstanding | 439.46M | 52W Low Chg | 75.00% |
Insider Own | 1.95% | ROA | 0.29% | Shares Float | 433.63M | Beta | 1.07 |
Inst Own | 85.84% | ROE | 2.38% | Shares Shorted/Prior | 6.19M/8.43M | Price | 6.02 |
Gross Margin | 5.68% | Profit Margin | 1.02% | Avg. Volume | 3,353,195 | Target Price | 7.00 |
Oper. Margin | -9.67% | Earnings Date | May 1 | Volume | 2,516,577 | Change | 0.50% |
Genworth Financial, Inc., together with its subsidiaries, provides mortgage and long-term care insurance products in the United States and internationally. It operates in three segments: Enact, Long-Term Care Insurance, and Life and Annuities. The Enact segment offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and pool mortgage insurance products. The Long-Term Care Insurance segment offers long-term care insurance products that are intended to protect against the significant and escalating costs of long-term care services provided in the insured's home, assisted living, and nursing facilities. The Life and Annuities segment provides protection and retirement income products, that includes traditional and non-traditional life insurance, such as term, universal and term universal life insurance, corporate-owned life insurance, and funding agreements; fixed annuities; and variable annuities. It distributes its products through sales force, in-house sales representatives, and digital marketing programs. The company was founded in 1871 and is headquartered in Richmond, Virginia.
Keefe, Bruyette & Woods | Market Perform | Apr 10, 24 |
Wells Fargo | Market Perform | Jun 11, 18 |
Compass Point | Buy | Nov 11, 16 |
BTIG | Neutral | Oct 5, 16 |
Goldman Sachs | Neutral | Sep 23, 16 |
Compass Point | Neutral | Sep 19, 16 |
UBS | Sell | Feb 9, 16 |
UBS | Sell | Jan 22, 16 |
Goldman Sachs | Neutral | Nov 17, 15 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
McInerney Thomas J | President and CEO; D.. President and CEO; Director | Aug 11 | Sell | 6.006 | 200,000 | 1,201,200 | 3,470,010 | 08/14/23 |
McInerney Thomas J | President and CEO; D.. President and CEO; Director | May 22 | Sell | 5.524 | 125,000 | 690,500 | 4,649,974 | 05/23/23 |
McInerney Thomas J | President and CEO; D.. President and CEO; Director | Feb 22 | Sell | 4.173 | 150,000 | 625,950 | 2,815,504 | 02/24/22 |